We are delighted to announce that Dr. Reddy’s Laboratories has been honored with the CPHI & PMEC India Award for Excellence in Ancillary Pharma Services - Supply Chain & Logistics. This prestigious award recognizes our outstanding efforts in enhancing customer experience through improved On-Time In-Full (OTIF) delivery and reduced back orders, achieved by integrating demand and supply chain management.
Key Achievements:
Enhanced OTIF Delivery: Our commitment to delivering products on time and in full has significantly improved, ensuring that our customers receive their orders exactly when and how they need them. This enhancement has been pivotal in building trust and reliability with our partners.
Reduced Back Orders: By streamlining our supply chain processes, we have successfully minimized back orders, ensuring a more efficient and responsive supply chain. This reduction has led to increased customer satisfaction and operational efficiency.
Integrated Demand and Supply Chain Management: Our innovative approach to integrating demand and supply chain management has been a game-changer. This integration allows us to better anticipate customer needs, optimize inventory levels, and respond swiftly to market changes.
This award is a testament to the hard work and dedication of our supply chain and logistics teams. Their relentless pursuit of excellence and innovation has set new benchmarks in the industry, and we are incredibly proud of their achievements.
We extend our gratitude to CPHI & PMEC India for this recognition and to our customers and partners for their continued support. Together, we are committed to driving excellence and delivering high- quality pharmaceutical solutions worldwide.
本網站上的任何信息,包括對任何產品或服務的任何提及,均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是,在某些情況下,雷迪博士可自行決定並根據當地法律要求,在存在此類監管豁免的任何地方,提供此類產品的研究數量,以根據《印度專利法》第 107A 條(Bolar 豁免)進行監管提交。購買者應對其各自市場的產品或服務(包括專利情況)進行獨立評估,並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證,包括但不限於適銷性、適用於特定用途和非侵權的保證。